Automated Immunoassay Analyzers Market worth over $25bn by 2024

in #immunoassay6 years ago

Market Overview and Growth Factors:

Rising prevalence of infectious diseases and growing geriatric population has led to high diagnostic test volumes, aiding a trend shift towards lab automation. Technological innovation for development of effective lab equipment will drive global automated immunoassay analyzers market.

Increasing consolidation in laboratories and hospitals in the wake of health care reform to curb healthcare expenses should stimulate the industry growth. Rising number of centralized laboratories and large reference labs should escalate the demand for automated immunoassay analyzer systems.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1727

Adoption of innovative diagnostic technologies should lead to prolific growth in automated immunoassay analyzers market. New product launches with ability to perform more than one test at a time using software allows diagnostic laboratories to perform routine as well as specialized tests.

Prominent Players:

Some of the prominent industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.

The automated immunoassay analyzers market is dominated by few companies with a strong financial muscle, expanded geographical footprint, and extensive product portfolio. New product launch or customizing existing product by adding broad assay of test menus is the major trend adopted by industry participants to hold their market position.

Regional Analysis:

Infectious diseases should witness a healthy growth to surpass USD 7 billion by 2024. Rising incidence of infectious diseases, growing elderly population and improved healthcare systems is set to drive segment growth.

U.S. automated immunoassay analyzers market accounted for more than 90% of regional industry revenue in 2016. Favorable healthcare reforms for diagnostic care, adoption of innovative products and increasing consolidation of laboratories should boost demand for automated instruments used for high volume testing.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1727

Coin Marketplace

STEEM 0.21
TRX 0.26
JST 0.040
BTC 101296.09
ETH 3673.80
USDT 1.00
SBD 3.15